Daito Pharmaceutical Co., Ltd. Logo

Daito Pharmaceutical Co., Ltd.

Manufactures APIs, generic drugs, and health foods; provides contract manufacturing services.

4577 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
富山市八日町326番地
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Daito Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of pharmaceutical products. The company operates an integrated business model that covers the entire production process, from active pharmaceutical ingredients (APIs) to finished formulation products, including powders, granules, and tablets. Its portfolio consists of generic drugs (both prescription and over-the-counter), health foods, and quasi-drugs. In addition to its own products, Daito serves other pharmaceutical firms by supplying APIs for generic products and offering contract manufacturing (CMO) services. The company emphasizes a stable supply of high-quality products managed by a strict quality assurance system.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Daito Pharmaceutical Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-27 08:15
Regulatory News Service
確認書
Japanese 8.3 KB
2025-08-27 08:13
Annual Report
有価証券報告書-第83期(2024/06/01-2025/05/31)
Japanese 1.4 MB
2025-06-12 09:16
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.3 KB
2025-05-13 09:22
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 26.0 KB
2025-04-11 08:53
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.3 KB
2025-03-12 08:08
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 24.7 KB
2025-02-13 08:56
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 24.2 KB
2025-01-17 09:04
Regulatory News Service
臨時報告書
Japanese 34.3 KB
2025-01-10 08:56
Regulatory News Service
確認書
Japanese 8.3 KB
2025-01-10 08:54
Interim Report
半期報告書-第83期(2024/06/01-2025/05/31)
Japanese 194.9 KB
2024-09-02 08:00
Regulatory News Service
臨時報告書
Japanese 21.8 KB
2024-08-30 07:43
Regulatory News Service
確認書
Japanese 8.2 KB
2024-08-30 07:41
Regulatory News Service
内部統制報告書-第82期(2023/06/01-2024/05/31)
Japanese 22.1 KB
2024-08-30 07:38
Annual Report
有価証券報告書-第82期(2023/06/01-2024/05/31)
Japanese 1.3 MB
2024-08-28 09:43
Regulatory News Service
臨時報告書
Japanese 20.4 KB

Automate Your Workflow. Get a real-time feed of all Daito Pharmaceutical Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Daito Pharmaceutical Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
StemRIM Inc. Logo
Developing regenerative medicines that use the body's own stem cells to treat intractable diseases.
Japan 4599
STENOCARE A/S Logo
Develops and distributes prescription medical cannabis oils in Northern Europe and Australia.
Denmark STENO
ST PHARM CO., LTD. Logo
A global CDMO specializing in APIs and RNA therapeutics for the gene therapy market.
South Korea 237690
Sugentech, Inc. Logo
Develops advanced in-vitro diagnostic systems for hospitals, clinics, and at-home use.
South Korea 253840
SUHEUNG CO.,LTD. Logo
Global manufacturer of capsules and contract manufacturing for pharma/nutraceutical industries.
South Korea 008490
Sumitomo Pharma Co., Ltd. Logo
R&D pharma creating medicines for oncology, psychiatry & neurology, focusing on Japan & the US.
Japan 4506
SunBio, Inc. Logo
Develops biopharmaceuticals and devices like artificial blood using proprietary PEGylation technology.
South Korea 067370
Swedish Orphan Biovitrum Logo
Develops innovative therapies for rare diseases in haematology, immunology, and specialty care.
Sweden SOBI
SymBio Pharmaceuticals Limited Logo
Acquires and commercializes specialty drugs for unmet needs in Japan and the Asia-Pacific region.
Japan 4582
SynAct Pharma Logo
Biotech developing oral therapies to resolve inflammation in diseases like rheumatoid arthritis.
Sweden SYNACT

Talk to a Data Expert

Have a question? We'll get back to you promptly.